LDLR and Disorder of lipid metabolism: In conclusion, our results demonstrated that berberine at low dose in combination with resveratrol may be a better therapy than monotherapy during the lipid metabolism disorder scenario, which was closely associated with enhanced LDLR expression by Res-mediated intracellular accumulation of Ber.